Literature DB >> 33550662

Unveiling the binding mode of perfluorooctanoic acid to human serum albumin.

Lorenzo Maso1, Matteo Trande2, Stefano Liberi2, Giulia Moro2,3, Elise Daems3,4, Sara Linciano2, Frank Sobott4,5, Sonia Covaceuszach6, Alberto Cassetta6, Silvano Fasolato7, Ligia M Moretto2, Karolien De Wael3, Laura Cendron1, Alessandro Angelini2,8.   

Abstract

Perfluorooctanoic acid (PFOA) is a toxic compound that is absorbed and distributed throughout the body by noncovalent binding to serum proteins such as human serum albumin (hSA). Though the interaction between PFOA and hSA has been already assessed using various analytical techniques, a high resolution and detailed analysis of the binding mode is still lacking. We report here the crystal structure of hSA in complex with PFOA and a medium-chain saturated fatty acid (FA). A total of eight distinct binding sites, four occupied by PFOAs and four by FAs, have been identified. In solution binding studies confirmed the 4:1 PFOA-hSA stoichiometry and revealed the presence of one high and three low affinity binding sites. Competition experiments with known hSA-binding drugs allowed locating the high affinity binding site in sub-domain IIIA. The elucidation of the molecular basis of the interaction between PFOA and hSA might provide not only a better assessment of the absorption and elimination mechanisms of these compounds in vivo but also have implications for the development of novel molecular receptors for diagnostic and biotechnological applications.
© 2021 The Protein Society.

Entities:  

Keywords:  binding mode; crystal structure; fluoroalkyl substances; human serum albumin; molecular interaction; perfluorooctanoic acid

Mesh:

Substances:

Year:  2021        PMID: 33550662      PMCID: PMC7980502          DOI: 10.1002/pro.4036

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.

Authors:  Roman A Laskowski; Mark B Swindells
Journal:  J Chem Inf Model       Date:  2011-10-05       Impact factor: 4.956

2.  Molecular interactions between some non-steroidal anti-inflammatory drugs (NSAID's) and bovine (BSA) or human (HSA) serum albumin estimated by means of isothermal titration calorimetry (ITC) and frontal analysis capillary electrophoresis (FA/CE).

Authors:  Clara Ràfols; Sílvia Zarza; Elisabeth Bosch
Journal:  Talanta       Date:  2014-07-05       Impact factor: 6.057

3.  Molecular interactions between warfarin and human (HSA) or bovine (BSA) serum albumin evaluated by isothermal titration calorimetry (ITC), fluorescence spectrometry (FS) and frontal analysis capillary electrophoresis (FA/CE).

Authors:  Clara Ràfols; Susana Amézqueta; Elisabet Fuguet; Elisabeth Bosch
Journal:  J Pharm Biomed Anal       Date:  2017-12-18       Impact factor: 3.935

4.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.

Authors:  S Curry; H Mandelkow; P Brick; N Franks
Journal:  Nat Struct Biol       Date:  1998-09

Review 5.  Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.

Authors:  Daniella M Pizzurro; Mara Seeley; Laura E Kerper; Barbara D Beck
Journal:  Regul Toxicol Pharmacol       Date:  2019-05-09       Impact factor: 3.271

6.  Structural basis of the drug-binding specificity of human serum albumin.

Authors:  Jamie Ghuman; Patricia A Zunszain; Isabelle Petitpas; Ananyo A Bhattacharya; Masaki Otagiri; Stephen Curry
Journal:  J Mol Biol       Date:  2005-10-14       Impact factor: 5.469

7.  Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.

Authors:  A A Bhattacharya; T Grüne; S Curry
Journal:  J Mol Biol       Date:  2000-11-10       Impact factor: 5.469

8.  Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin.

Authors:  Yan-Min Chen; Liang-Hong Guo
Journal:  Arch Toxicol       Date:  2008-10-15       Impact factor: 5.153

9.  Binding of perfluorocarboxylates to serum albumin: a comparison of analytical methods.

Authors:  Laura A MacManus-Spencer; Monica L Tse; Paul C Hebert; Heather N Bischel; Richard G Luthy
Journal:  Anal Chem       Date:  2010-02-01       Impact factor: 6.986

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  2 in total

1.  Unveiling the binding mode of perfluorooctanoic acid to human serum albumin.

Authors:  Lorenzo Maso; Matteo Trande; Stefano Liberi; Giulia Moro; Elise Daems; Sara Linciano; Frank Sobott; Sonia Covaceuszach; Alberto Cassetta; Silvano Fasolato; Ligia M Moretto; Karolien De Wael; Laura Cendron; Alessandro Angelini
Journal:  Protein Sci       Date:  2021-03-05       Impact factor: 6.725

2.  Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil.

Authors:  Stefano Liberi; Sara Linciano; Giulia Moro; Luca De Toni; Laura Cendron; Alessandro Angelini
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.